Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

100%(4 trials)

Phase Distribution

Ph phase_2

25%

Ph phase_3

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 3Large-scale testing

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 21 (25.0%)

Phase 33 (75.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_2

Comparison of PET Amyloid Imaging in Japanese and Western Subjects

NCT02813070

completedphase_3

Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels

NCT01165554

completedphase_3

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

NCT01265394

completedphase_3

PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

NCT01053312

Clinical Trials (4)

Showing 4 of 4 trials

NCT02813070Phase 2

Comparison of PET Amyloid Imaging in Japanese and Western Subjects

Completed

NCT01165554Phase 3

Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels

Completed

NCT01265394Phase 3

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Completed

NCT01053312Phase 3

PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4